न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lorazepam 0.5mg (3% overage added) - tablet - 0.5 mg - active: lorazepam 0.5mg (3% overage added) excipient: indigo carmine lactose monohydrate magnesium stearate microcrystalline cellulose polacrilin potassium - ativan (lorazepam) is useful in the therapy of most disorders in which anxiety is a major component. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. treatment of moderate to severe anxiety.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lorazepam 1mg;   - tablet - 1 mg - active: lorazepam 1mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose polacrilin potassium - ativan (lorazepam) is useful in the therapy of most disorders in which anxiety is a major component. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. treatment of moderate to severe anxiety.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - lorazepam 2.5mg;   - tablet - 2.5 mg - active: lorazepam 2.5mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose polacrilin potassium - ativan (lorazepam) is useful in the therapy of most disorders in which anxiety is a major component. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. treatment of moderate to severe anxiety.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - benzoyl peroxide 2.5%{relative};   - topical gel - 2.5% w/w - active: benzoyl peroxide 2.5%{relative}   excipient: acrylates copolymer carbomer 940 colloidal silicon dioxide disodium edetate dihydrate docusate sodium glycerol poloxamer propylene glycol sodium hydroxide water - latest regulatory activity

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - benzoyl peroxide 5%{relative};   - topical gel - 5% w/w - active: benzoyl peroxide 5%{relative}   excipient: acrylates copolymer carbomer 940 colloidal silicon dioxide disodium edetate dihydrate docusate sodium glycerol poloxamer propylene glycol sodium hydroxide water - latest regulatory activity

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - captopril 5.5 mg/ml (includes 10% excess);  ;  ; captopril 5.5 mg/ml - oral solution - 5 mg/ml - active: captopril 5.5 mg/ml (includes 10% excess)     excipient: citric acid disodium edetate dihydrate hydrochloric acid purified water sodium benzoate sodium citrate dihydrate sodium hydroxide active: captopril 5.5 mg/ml excipient: citric acid disodium edetate dihydrate hydrochloric acid purified water sodium benzoate sodium citrate dihydrate sodium hydroxide - capoten (captopril) is indicated for the treatment of hypertension. in using capoten, consideration should be given to the risk of neutropenia/agranulocytosis. capoten is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - celecoxib 100mg;  ;   - capsule - 100 mg - active: celecoxib 100mg     excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate povidone sodium laurilsulfate - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - celecoxib 200mg;  ;   - capsule - 200 mg - active: celecoxib 200mg     excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate povidone sodium laurilsulfate - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - celecoxib 400mg;   - capsule - 400 mg - active: celecoxib 400mg   excipient: croscarmellose sodium gelatin lactose monohydrate magnesium stearate povidone sodium laurilsulfate tekprint green sb-4027 titanium dioxide - symptomatic treatment of pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. for the management of acute pain and treatment of primary dysmenorrhoea in adults. the decision to prescribe a selective cox-2 inhibitor should only be made: · if non-pharmacological interventions and simple analgesic therapies have been tried and found to lack analgesic efficacy or to have unacceptable adverse effects in the individual patient, and · after assessment of the individual patient's overall risks. as the cardiovascular risks of the selective cox-2 inhibitors may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. patients on long-term treatment should be reviewed regularly, such as every three months, with regards to efficacy, risk factors and ongoing need for treatment.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - enoxaparin sodium 100 mg/ml;   - solution for injection - 100 mg/ml - active: enoxaparin sodium 100 mg/ml   excipient: water for injection - prophylaxis of venous thromboembolism in general medical patients bedridden due to acute illnesses including acute heart failure, respiratory failure, severe infections, rheumatic disease. prophylaxis of venous thromboembolic disease, in particular those which may be associated with orthopaedic, general, major colorectal or cancer surgery.